Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial

Hiddo J.L. Heerspink, Arihiro Kiyosue, David C. Wheeler, Min Lin, Emma Wijkmark, Glenn Carlson, Anne‐Kristina Mercier, Magnus Åstrand, Sebastian Ueckert, Peter J. Greasley, Phil Ambery